HomeALMR • NASDAQ
add
Alamar Biosciences Inc
Previous close
$17.00
Day range
$21.50 - $24.50
Year range
$21.50 - $24.50
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | 2025info | Y/Y change |
|---|---|---|
Revenue | 74.21M | 195.17% |
Operating expense | 73.04M | 25.55% |
Net income | -29.82M | 36.65% |
Net profit margin | -40.18 | 78.54% |
Earnings per share | — | — |
EBITDA | -27.47M | 40.76% |
Effective tax rate | -2.28% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 30.00M | -62.19% |
Total assets | 139.99M | -6.37% |
Total liabilities | 63.95M | 33.43% |
Total equity | 76.04M | — |
Shares outstanding | 29.13M | — |
Price to book | -3.11 | — |
Return on assets | -13.53% | — |
Return on capital | -15.53% | — |
Cash Flow
Net change in cash
| (USD) | 2025info | Y/Y change |
|---|---|---|
Net income | -29.82M | 36.65% |
Cash from operations | -53.61M | 2.91% |
Cash from investing | 46.18M | 185.62% |
Cash from financing | 10.84M | -90.45% |
Net change in cash | 3.23M | -24.29% |
Free cash flow | -49.70M | — |
About
Founded
2018
Website
Employees
222
